Literature DB >> 28966946

Expression and Purification of a Mammalian P2X7 Receptor from Sf9 Insect Cells.

Akira Karasawa1, Toshimitsu Kawate1.   

Abstract

The P2X7 receptor is an extracellular ATP-gated ion channel found only in eukaryotes (Bartlett et al., 2014). Due to its unique properties among P2X receptors, such as formation of a large conductance pore, the P2X7 receptor has been implicated in devastating diseases like chronic pain (North and Jarvis, 2013). However, mechanisms underlying the P2X7 specific properties remain poorly understood, partly because purification of this eukaryotic membrane protein has been challenging. Here we describe a detailed protocol for expressing and purifying a mammalian P2X7 receptor using an insect cell-baculovirus system. The P2X7 receptor is expressed in Sf9 insect cells as a GFP fusion protein and solubilized with a buffer containing Triton X-100 detergent. The P2X7-GFP fusion protein is then purified in a buffer containing dodecyl maltoside using Strep-Tactin affinity chromatography. Following enzymatic cleavage of the attached GFP and Strep-tag by thrombin, the P2X7 receptor is isolated using size exclusion chromatography. This method typically yields ~2 mg of purified protein from 6 L of Sf9 culture. Purified protein can be stored with a buffer containing 15% glycerol at 4 °C for at least 2 months and used for a variety of functional and structural studies (Karasawa and Kawate, 2016).

Entities:  

Keywords:  Baculovirus expression system; Eukaryotic membrane protein; P2X7; Sf9

Year:  2017        PMID: 28966946      PMCID: PMC5621764          DOI: 10.21769/BioProtoc.2544

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  7 in total

1.  Molecular mechanism of ATP binding and ion channel activation in P2X receptors.

Authors:  Motoyuki Hattori; Eric Gouaux
Journal:  Nature       Date:  2012-05-10       Impact factor: 49.962

Review 2.  The P2X7 receptor: shifting from a low- to a high-conductance channel - an enigmatic phenomenon?

Authors:  Luiz Anastacio Alves; Ricardo Augusto de Melo Reis; Cristina Alves Magalhães de Souza; Monica Santos de Freitas; Pedro Celso Nogueira Teixeira; Dinarte Neto Moreira Ferreira; Robson Faria Xavier
Journal:  Biochim Biophys Acta       Date:  2014-05-21

Review 3.  P2X receptors as drug targets.

Authors:  R Alan North; Michael F Jarvis
Journal:  Mol Pharmacol       Date:  2012-12-19       Impact factor: 4.436

Review 4.  The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease.

Authors:  Rachael Bartlett; Leanne Stokes; Ronald Sluyter
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

Review 5.  The microglial ATP-gated ion channel P2X7 as a CNS drug target.

Authors:  Anindya Bhattacharya; Knut Biber
Journal:  Glia       Date:  2016-05-24       Impact factor: 7.452

6.  Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.

Authors:  Erkan Karakas; Noriko Simorowski; Hiro Furukawa
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

7.  Structural basis for subtype-specific inhibition of the P2X7 receptor.

Authors:  Akira Karasawa; Toshimitsu Kawate
Journal:  Elife       Date:  2016-12-09       Impact factor: 8.140

  7 in total
  3 in total

Review 1.  P2X7 as a scavenger receptor for innate phagocytosis in the brain.

Authors:  Ben J Gu; James S Wiley
Journal:  Br J Pharmacol       Date:  2018-10-05       Impact factor: 8.739

2.  Methods for Studying Cholesterol-Dependent Regulation of P2X7 Receptors.

Authors:  Ruth D Murrell-Lagnado; Toshimitsu Kawate
Journal:  Methods Mol Biol       Date:  2022

3.  GPCR19 Regulates P2X7R-Mediated NLRP3 Inflammasomal Activation of Microglia by Amyloid β in a Mouse Model of Alzheimer's Disease.

Authors:  Jahirul Islam; Jung-Ah Cho; Ju-Yong Kim; Kyung-Sun Park; Young-Jae Koh; Chu Young Chung; Eun-Jae Lee; Soo Jeong Nam; Kyoungyul Lee; Seoung-Heon Kim; Sung-Hye Park; Dong Young Lee; Byeong C Kim; Kyung-Hwa Lee; Seung-Yong Seong
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.